Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches

Breast cancer (BC) and ovarian cancer (OC) are among the most common and deadly cancers affecting women worldwide. Both are complex diseases with marked heterogeneity. Despite the induction of screening programs that increase the frequency of earlier diagnosis of BC, at a stage when the cancer is mo...

Full description

Bibliographic Details
Main Authors: Ivan Lučić, Matea Kurtović, Monika Mlinarić, Nikolina Piteša, Ana Čipak Gašparović, Maja Sabol, Lidija Milković
Format: Article
Language:English
Published: MDPI AG 2023-06-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/24/13/10683
_version_ 1797591566930411520
author Ivan Lučić
Matea Kurtović
Monika Mlinarić
Nikolina Piteša
Ana Čipak Gašparović
Maja Sabol
Lidija Milković
author_facet Ivan Lučić
Matea Kurtović
Monika Mlinarić
Nikolina Piteša
Ana Čipak Gašparović
Maja Sabol
Lidija Milković
author_sort Ivan Lučić
collection DOAJ
description Breast cancer (BC) and ovarian cancer (OC) are among the most common and deadly cancers affecting women worldwide. Both are complex diseases with marked heterogeneity. Despite the induction of screening programs that increase the frequency of earlier diagnosis of BC, at a stage when the cancer is more likely to respond to therapy, which does not exist for OC, more than 50% of both cancers are diagnosed at an advanced stage. Initial therapy can put the cancer into remission. However, recurrences occur frequently in both BC and OC, which are highly cancer-subtype dependent. Therapy resistance is mainly attributed to a rare subpopulation of cells, named cancer stem cells (CSC) or tumor-initiating cells, as they are capable of self-renewal, tumor initiation, and regrowth of tumor bulk. In this review, we will discuss the distinctive markers and signaling pathways that characterize CSC, their interactions with the tumor microenvironment, and the strategies they employ to evade immune surveillance. Our focus will be on identifying the common features of breast cancer stem cells (BCSC) and ovarian cancer stem cells (OCSC) and suggesting potential therapeutic approaches.
first_indexed 2024-03-11T01:40:15Z
format Article
id doaj.art-9f0c3fb603484ec98d1e24d342c45f69
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-11T01:40:15Z
publishDate 2023-06-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-9f0c3fb603484ec98d1e24d342c45f692023-11-18T16:41:55ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672023-06-0124131068310.3390/ijms241310683Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic ApproachesIvan Lučić0Matea Kurtović1Monika Mlinarić2Nikolina Piteša3Ana Čipak Gašparović4Maja Sabol5Lidija Milković6Laboratory for Oxidative Stress, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Oxidative Stress, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Oxidative Stress, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Hereditary Cancer, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaLaboratory for Oxidative Stress, Division of Molecular Medicine, Ruđer Bošković Institute, 10000 Zagreb, CroatiaBreast cancer (BC) and ovarian cancer (OC) are among the most common and deadly cancers affecting women worldwide. Both are complex diseases with marked heterogeneity. Despite the induction of screening programs that increase the frequency of earlier diagnosis of BC, at a stage when the cancer is more likely to respond to therapy, which does not exist for OC, more than 50% of both cancers are diagnosed at an advanced stage. Initial therapy can put the cancer into remission. However, recurrences occur frequently in both BC and OC, which are highly cancer-subtype dependent. Therapy resistance is mainly attributed to a rare subpopulation of cells, named cancer stem cells (CSC) or tumor-initiating cells, as they are capable of self-renewal, tumor initiation, and regrowth of tumor bulk. In this review, we will discuss the distinctive markers and signaling pathways that characterize CSC, their interactions with the tumor microenvironment, and the strategies they employ to evade immune surveillance. Our focus will be on identifying the common features of breast cancer stem cells (BCSC) and ovarian cancer stem cells (OCSC) and suggesting potential therapeutic approaches.https://www.mdpi.com/1422-0067/24/13/10683breast cancerovarian cancercancer stem cells (CSC)CSC markerssignaling pathwaystumor microenvironment
spellingShingle Ivan Lučić
Matea Kurtović
Monika Mlinarić
Nikolina Piteša
Ana Čipak Gašparović
Maja Sabol
Lidija Milković
Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
International Journal of Molecular Sciences
breast cancer
ovarian cancer
cancer stem cells (CSC)
CSC markers
signaling pathways
tumor microenvironment
title Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
title_full Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
title_fullStr Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
title_full_unstemmed Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
title_short Deciphering Common Traits of Breast and Ovarian Cancer Stem Cells and Possible Therapeutic Approaches
title_sort deciphering common traits of breast and ovarian cancer stem cells and possible therapeutic approaches
topic breast cancer
ovarian cancer
cancer stem cells (CSC)
CSC markers
signaling pathways
tumor microenvironment
url https://www.mdpi.com/1422-0067/24/13/10683
work_keys_str_mv AT ivanlucic decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT mateakurtovic decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT monikamlinaric decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT nikolinapitesa decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT anacipakgasparovic decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT majasabol decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches
AT lidijamilkovic decipheringcommontraitsofbreastandovariancancerstemcellsandpossibletherapeuticapproaches